SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against CytRx Corp. & Encourag...
August 17 2016 - 6:01PM
Business Wire
Khang & Khang LLP (the “Firm”) announces that a class action
lawsuit was filed against CytRx Corporation (“CytRx” or the
“Company”) (Nasdaq: CYTR). Investors who purchased or otherwise
acquired shares between November 18, 2014 and July 11, 2016
inclusive (the “Class Period”), are encouraged to contact the Firm
prior to the September 23, 2016 lead plaintiff motion
deadline.
If you purchased CytRx shares during the Class Period, please
contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von
Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949)
419-3834, or by e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until
certification occurs, you are not represented by an attorney. You
may choose to take no action and remain a passive class member.
The complaint alleges that the Company made materially false and
misleading statements and/or failed to disclose that: the clinical
hold placed on the Phase 3 trial of aldoxorubicin would prevent
sufficient follow-up for patients involved in the study; that
almost half of the patients would be excluded from the progression
free survival evaluation; CytRx would like conduct a second
analysis; that the results of the trial could be affected or
approval of aldoxorubicin could be delayed; and that as a result of
the above, the Company’s statements were false and misleading
and/or lacked a reasonable basis at all relevant times.
If you wish to learn more about this lawsuit, or if
you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two
decades, by telephone: (949) 419-3834, or by e-mail at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160817006284/en/
Khang & Khang LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From Apr 2024 to May 2024
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From May 2023 to May 2024